PDE4B drugs for Idiopathic Pulmonary Fibrosis
2 tracked PDE4B drugs in the Idiopathic Pulmonary Fibrosis race. The class explanation lives on the PDE4B page; the full indication pipeline across every mechanism is on the Idiopathic Pulmonary Fibrosis page.
1 approved / phase 41 Phase 3
Head-to-head evidence: HSK44459 vs Nerandomilast (Jascayd)